Pigny Pascal, Vincent Audrey, Cardot Bauters Catherine, Bertrand Monelle, de Montpreville Vincent Thomas, Crepin Michel, Porchet Nicole, Caron Philippe
Laboratoire de Biochimie et Hormonologie, Centre de Biologie et Pathologie, Centre Hospitalier Régional & Universitaire, Lille cedex, France.
J Clin Endocrinol Metab. 2008 May;93(5):1609-15. doi: 10.1210/jc.2007-1989. Epub 2008 Jan 22.
Inactivating mutations of SDHD, which is mapped to 11q23 and encodes the cybS subunit of succinate dehydrogenase, predispose to hereditary paraganglioma (PGL) and/or pheochromocytoma. So far no disease was shown to occur in case of maternal transmission of a SDHD mutation, suggesting the existence of genomic imprinting. A hypothetic model, involving the loss of the maternal copy of a tumor suppressor gene mapped to 11p15 in the tumoral tissue, has been proposed to explain this mode of inheritance.
Our objective was to investigate the possibility of maternal transmission of SDHD-linked PGL.
A three-generation family carrying the SDHD W43X mutation was studied at the clinical, pathological, and genetical levels.
The germline's mutation was probably inherited from the grandfather. In the second generation, three carriers (two females and one male), who had the same at risk 11q13-q23 haplotype, developed multiple cervical PGLs. In the third generation, one boy received the mutation from his mother and developed a glomus tympanicum PGL at 11 yr. He shared only the 11q23 haplotype with the other affected members of the family. Methylation analysis of the differentially methylated region upstream of the maternally expressed H19 gene, mapped to 11p15, showed that the seventh CTCF binding site is hypermethylated in the germline of the affected boy suggesting a gain of imprinting.
Our data show that maternal transmission of a SDHD-linked PGL, even if a rare event, can occur. Therefore, we propose that children who inherited a pathogenic mutation from their mother should be considered as at risk of PGL.
SDHD基因定位于11q23,编码琥珀酸脱氢酶的CybS亚基,其失活突变易导致遗传性副神经节瘤(PGL)和/或嗜铬细胞瘤。迄今为止,尚未发现SDHD突变母系遗传的病例会发病,这提示存在基因组印记现象。有人提出一种假设模型,认为肿瘤组织中定位于11p15的肿瘤抑制基因母本拷贝缺失可解释这种遗传方式。
我们的目的是研究与SDHD相关的PGL母系遗传的可能性。
对一个携带SDHD W43X突变的三代家系进行临床、病理和遗传学研究。
种系突变可能遗传自祖父。在第二代中,三名携带者(两名女性和一名男性)具有相同的11q13 - q23风险单倍型,均发生了多发性颈部PGL。在第三代中,一名男孩从母亲那里遗传了该突变,并在11岁时发生了鼓室球瘤PGL。他仅与家族中其他患病成员共享11q23单倍型。对定位于11p15的母源表达的H19基因上游差异甲基化区域进行甲基化分析,结果显示,患病男孩的种系中第七个CTCF结合位点发生了高甲基化,提示印记增强。
我们的数据表明,与SDHD相关的PGL母系遗传即使是罕见事件也可能发生。因此,我们建议,从母亲那里遗传了致病突变的儿童应被视为有患PGL的风险。